Abstract
Type 1 neurofibromatosis, also known as von Recklinghausen disease, is one of the most common genetic disorders. Gastrointestinal associations have been well described in these patients, but the true incidence of gastrointestinal tumors and the proportion of these becoming clinically significant are not known. The most common gastrointestinal tumors are stromal tumors, most of which are located in the stomach and jejunum. We discuss the case of a female patient with neurofibromatosis whose initial diagnosis was an ovarian mass. During surgery the diagnosis of an intestinal stromal tumor was made. Operative findings were a multilobulated tumor arising from the ileal wall 50 cm from the ileocecal valve. The tumor did not originate from the nervous myenteric plexus or muscular layer of the small bowel wall; it originated from within the stromal cells of the intestinal wall. Mitotic count showed 3 mitoses per 10 high-power fields. Immunohistochemical stains of the tumor showed positive staining for CD117 and CD34 and negative staining for S100, α-smooth muscle actin, and desmin. The intestinal myenteric plexus showed positive staining for chromegranin A and S100. The histologic characteristics of this patient’s tumor are compatible with an undifferentiated stromal tumor of nonneural or nonmuscular origin.
Similar content being viewed by others
References
von Recklinghausen FD. Ueber die multiplen fibrome der Hautund inhre beziehung zu den multiplen neuromen. Berlin: Hirschwald, 1882.
Lynch TM, Gutmann DH. Neurofibromatosis 1. Neurol Clin N Am 2002;20:841–865.
Seymour-Dempsey K, Andrassy RJ. Neurofibromatosis: implications for the general surgeon. J Am Coll Surg 2002; 195:553–561.
Giuly JA, Picand R, Giuly D, Monges B, Nguyen-Cat R. Von Recklinghausen disease and gastrointestinal stromal tumors. Am J Surg 2003;185:86–87.
Joo M, Lee K, Kim H, Kim MK, Chi JG. Multiple small intestinal stromal tumors associated with neurofibromatosis 1. Yonsei Med J 2004;45:564–567.
Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106–1116.
Behranwala KA, Spalding D, Wotherspoon A, Fisher C, Thompson JN. Small bowel gastrointestinal stromal tumors and ampullary cancer in type 1 neurofibromatosis. World J Surg Oncol 2004;2:1–4.
Özgüc H, Yilmazlar T, Yerci Ö, et al. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J GASTROINTEST SURG 2005;9:418–429.
Dulai GS, Jensen DM. Severe gastrointestinal bleeding of obscure origin. Gastrointest Endosc Clin N Am 2004;14:101–113.
Dukhno PI, Levy OA. Gastrointestinal complications of von Recklinghausen’s disease: two case reports and a review of the literature. Scand J Gastroenterol 2003;38:1275–1278.
Bhattacharyya R, Jamieson GG. Recurrent perforation complicating intestinal neurofibromatosis. Aust N Z J Surg 1988; 58:749–751.
Carlomagno G, Beneduce P. A gastrointestinal tumor (GIST) masquerading as an ovarian mass. World J Surg Oncol 2004; 2:15–17.
NIH Consensus Development Conference. Neurofibromatosis conference statement. Arch Neurol 1988;45:575–578.
Cho H, Kobayashi O, Tsuburaya A, et al. Metastatic gastrointestinal stromal tumor with an Exon 11 c-Kit mutation responding to the tyrosine kinase inhibitor imatinib. Dig Surg 2004;21:74–77.
de Vos tot Nederveen Cappel RJ, van Hillegersberg R, Rodenhuis S, Peterse JL, van Coevorden F. Downstaging of an advanced gastrointestinal stromal tumor by neoadjuvant imatinib. Dig Surg 2004;21:77–79.
Fletcher CDM, Berman JJ, Corless C. Diagnosis of gastrointestinal stromal tumors; a consensus approach. Int J Surg Pathol 2002;10:81–89.
Croom KF, Perry CM. Imatinib mesylate: in the treatment of gastrointestinal stromal tumors. Drugs 2003;63:513–522.
Eisenberg BL, Judson I. Surgery and imatinib in the treatment of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004;11:465–475.
de Mestier P, Guetz GD. Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics. World J Surg 2005;29:357–362.
ChengSP,Huang MJ, YangTL, et al. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci 2004;49:1165–1169.
Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001;61:8118–8121.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beltran, M.A., Cruces, K.S., Barría, C. et al. Multiple gastrointestinal stromal tumors of the ileum and neurofibromatosis type 1. J Gastrointest Surg 10, 297–301 (2006). https://doi.org/10.1016/j.gassur.2005.05.007
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.05.007